The average cell proportion of CD8+T and CD4+T was 5.6% and 7.8% in BC, 14% and 11% in CRC, 17% and 16% in ESCA, and 2.4 and 4.7% in PDAC (Supplementary Table S2). Here, CD8A is linked to breast cancer.